A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430

Clinical trial NCT02319772 · COMPLETED

Trial details

NCT number: NCT02319772
Sponsor: BioCryst Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Filovirus Infections Ebola Virus Infection

Start date: 2014-12-01
Primary completion: 2016-03-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.